Veracyte officer plans sale of 4,015 shares, $160K

Available on EDGAR 09/21/2026 - 04:32 PM EDT Accepted by SEC EDGAR 09/21/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) received a Form 144 notice indicating that officer John Leite plans to sell up to 4,015 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of approximately $159,776.93 and are listed on NASDAQ. The shares originate from Restricted Stock Units acquired from the issuer on September 2, 2026.

Key Figures

Shares to be sold: 4,015 shares Aggregate market value: $159,776.93 Acquisition date of RSU shares: September 2, 2026 +1 more

4 metrics

Shares to be sold 4,015 shares Planned sale of Veracyte common stock under Rule 144 by officer John Leite

Aggregate market value $159,776.93 Reported aggregate market value of the 4,015 Veracyte shares to be sold

Acquisition date of RSU shares September 2, 2026 Date the Restricted Stock Units from which the shares derive were acquired from the issuer

Proposed sale date September 21, 2026 Date associated with the planned NASDAQ sale of Veracyte common stock

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, common stock

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/02/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"4015 | 159776.93 | 80390731 | 09/21/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

common stock financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for VCYT?

The filing discloses that officer John Leite plans to sell up to 4,015 shares of Veracyte common stock under Rule 144, with the transaction to be executed through Morgan Stanley Smith Barney LLC.

How many VERACYTE, INC. (VCYT) shares are planned to be sold?

The Form 144 indicates a planned sale of 4,015 shares of Veracyte common stock. These shares are associated with Restricted Stock Units acquired from the issuer.

What is the aggregate market value of the VCYT shares in this Form 144?

The notice reports an aggregate market value of $159,776.93 for the 4,015 Veracyte common shares to be sold under Rule 144.

When were the VCYT shares to be sold by John Leite acquired?

The shares to be sold originate from Restricted Stock Units acquired from VERACYTE, INC. on September 2, 2026, according to the Form 144 disclosure.

On which market are the VCYT shares listed in this Form 144?

The Form 144 states that the Veracyte common stock covered by the notice is listed on NASDAQ.

Which broker is handling the planned VCYT share sale?

The planned Rule 144 sale of 4,015 Veracyte common shares is to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services in New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001991536
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERACYTE, INC.
SEC File Number	001-36156
Address of Issuer	6000 Shoreline Court, Suite 300 South San Francisco CALIFORNIA 94080
Phone	6502436300
Name of Person for Whose Account the Securities are To Be Sold	JOHN LEITE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4015	159776.93	80390731	09/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2026	Restricted Stock Units	Issuer			4015	09/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Leite
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)